Page last updated: 2024-09-05

cp 100356 and dofequidar

cp 100356 has been researched along with dofequidar in 1 studies

Compound Research Comparison

Studies
(cp 100356)
Trials
(cp 100356)
Recent Studies (post-2010)
(cp 100356)
Studies
(dofequidar)
Trials
(dofequidar)
Recent Studies (post-2010) (dofequidar)
8034025

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Guengerich, P; Kajiji, S; Kim, RB; Wandel, C; Wilkinson, GR; Wood, AJ1

Other Studies

1 other study(ies) available for cp 100356 and dofequidar

ArticleYear
P-glycoprotein and cytochrome P-450 3A inhibition: dissociation of inhibitory potencies.
    Cancer research, 1999, Aug-15, Volume: 59, Issue:16

    Topics: Aryl Hydrocarbon Hydroxylases; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Caco-2 Cells; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Digoxin; Down-Regulation; Enzyme Inhibitors; Humans; Oxidoreductases, N-Demethylating; Substrate Specificity

1999